SCHEMBL16826355

SCHEMBL16826355

Nc1n[nH]c(N2CCN(Cc3ccc(F)cc3Cl)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GALR3 O60755 1/20 0.50
▸ NR2F2 P24468 1/20 0.50
▸ ALDH1A1 P00352 5/20 0.43
▸ GAA P10253 1/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ COMT P21964 1/20 0.41
▸ OXTR P30559 1/20 0.41
▸ P2RX7 Q99572 2/20 0.41
▸ ACHE P22303 2/20 0.41
▸ GPR6 P46095 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ RPS6KB1 P23443 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PLA2G1B P04054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16826422 0.83 ALDH1A1 (0.38) GALR3NR2F2ALDH1A1RAB9ASMN1; SMN2
SCHEMBL16825881 0.82 KDM4E (0.52) GAAACHERPS6KB1MAPTKDM4E
SCHEMBL16826091 0.78 POLB (0.56) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL16826236 0.77 SIGMAR1 (0.54) GAASMN1; SMN2POLB
SCHEMBL16825903 0.76 KDM4E (0.54) ALDH1A1GAARAB9ANPC1MEN1
SCHEMBL16826410 0.74 GAA (0.62) ALDH1A1GAARAB9ANPC1MEN1
SCHEMBL16825972 0.74 LMNA (0.51) ALDH1A1GAAMEN1KMT2AMAPT
SCHEMBL16825908 0.73 SIGMAR1 (0.57) ALDH1A1GAAMEN1KMT2AMAPT
SCHEMBL16826206 0.73 TP53 (0.42) ALDH1A1POLBCOMTGPR6KDM4E
SCHEMBL16826336 0.73 TNKS (0.50) GAAMEN1KMT2APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3082805-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME The Institute For Drug Delivery (US) 2016-10-26 — — EP claimed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US claimed
WO-2015095701-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME THE INSTITUTE FOR DRUG DELIVERY (US) 2015-06-25 — — WO claimed
EP-3082805-B1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INST FOR DRUG DISCOVERY LLC (US) 2020-02-05 — — EP disclosed
EP-3082805-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME The Institute For Drug Delivery (US) 2016-10-26 — — EP disclosed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US disclosed
WO-2015095701-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME THE INSTITUTE FOR DRUG DELIVERY (US) 2015-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME CMA1, CHIA, AADAC GALR3 273/4885NR2F2 4626/4885ALDH1A1 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback